New Age Alpha Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02M Sell
25,605
-538
-2% -$45.7K 0.09% 294
2026
Q1
$2.25M Sell
26,143
-516
-2% -$46.3K 0.1% 283
2025
Q4
$2.33M Buy
26,659
+977
+4% +$74.2K 0.1% 289
2025
Q3
$1.47M Sell
25,682
-775
-3% -$44.6K 0.06% 358
2025
Q2
$1.56M Buy
26,457
+2,688
+11% +$174K 0.07% 353
2025
Q1
$1.74M Buy
+23,769
New +$1.96M 0.08% 340

Other funds holding GMED

New Age Alpha Advisors's GMED Position: Q2 2026 in Review

New Age Alpha Advisors reduced its Globus Medical (GMED) stake by 2.1% in Q2 2026, selling an estimated $45.7K and leaving 25,605 shares worth $2.02M. The position accounts for 0.09% of the portfolio, ranked #294.

New Age Alpha Advisors first reported a position in GMED in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.33M in Q4 2025. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • New Age Alpha Advisors held 25,605 shares of Globus Medical worth $2.02M as of Q2 2026.
  • New Age Alpha Advisors sold 538 Globus Medical shares in Q2 2026, an estimated $45.7K.
  • Globus Medical made up 0.09% of New Age Alpha Advisors's portfolio in Q2 2026, its #294 holding.
  • New Age Alpha Advisors first reported a position in Globus Medical in Q1 2025 and has held it in 6 quarters since.
  • New Age Alpha Advisors's Globus Medical position peaked at $2.33M in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.